These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2140668)

  • 1. Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase II study of toremifene.
    Horvath G; Stendahl U; Kalling M; Fernö M; Himmelmann A; Hajba A
    Anticancer Res; 1990; 10(2A):323-5. PubMed ID: 2140668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of toremifene in carcinoma corporis uteri. Preliminary communication.
    Horváth G; Tropé C; Almbo HE
    J Steroid Biochem; 1990 Jun; 36(3):241. PubMed ID: 2142245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer--a comparative study by a double blind method with tamoxifen].
    Nomura Y; Tominaga T; Abe O; Izuo M; Ogawa N
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):247-58. PubMed ID: 8434963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
    Konstantinova MM; Gershanovich MA
    Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II study.
    Gundersen S
    J Steroid Biochem; 1990 Jun; 36(3):233-4. PubMed ID: 2142241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment.
    Jönsson PE; Malmberg M; Bergljung L; Ingvar C; Ericsson M; Ryden S; Nilsson I; Terje IJ
    Anticancer Res; 1991; 11(2):873-5. PubMed ID: 1829600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone therapy of advanced renal cancer with high-dose toremifene (Fareston)].
    Gershanovich ML; Moiseenko VM; Vorob'ev AV; Kiapiulia K
    Vopr Onkol; 1996; 42(5):105-9. PubMed ID: 9064893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communication.
    Pyrhönen S; Valavaara R; Heikkinen M; Rissanen P; Blanco G; Nordman E; Holsti LR; Hajba A
    J Steroid Biochem; 1990 Jun; 36(3):227-8. PubMed ID: 2142239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication.
    Modig H; Borgström S; Nilsson I; Westman G
    J Steroid Biochem; 1990 Jun; 36(3):235-6. PubMed ID: 2142242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].
    Wada N; Kobayashi H; Oka S; Ando J; Tamura H
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1935-42. PubMed ID: 12465393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early phase II study of TAT-59 in patients with advanced or recurrent breast cancer--a multicenter dose finding study].
    Aoyama H; Tominaga T; Abe O
    Gan To Kagaku Ryoho; 1998 May; 25(6):853-65. PubMed ID: 9617324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination].
    Chevallier B; Spielmann M; Marty M; Serin D; Pouillart P; Tubiana Hulin M; Mignot L; Pujade Lauraine E; Krams M; Mertens H
    Bull Cancer; 1993 Jul; 80(7):624-8. PubMed ID: 8204943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trials with toremifene in advanced breast cancer: a review.
    Valavaara R
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S31-5. PubMed ID: 2149283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of toremifene in breast cancer patients. A phase II study.
    Valavaara R; Pyrhönen S; Heikkinen M; Rissanen P; Blanco G; Nordman E; Taskinen P; Holsti LR; Hajba A
    J Steroid Biochem; 1990 Jun; 36(3):229-31. PubMed ID: 2142240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of high dose NK 622 (toremifene citrate) in tamoxifen failed patients with breast cancer].
    Asaishi K; Tominaga T; Abe O; Izuo M; Nomura Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):91-9. PubMed ID: 8422190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of estrogen receptors in tamoxifen and toremifene therapy.
    Valavaara R; Kangas L
    Ann Clin Res; 1988; 20(5):380-8. PubMed ID: 2975479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of NK 622 (toremifene citrate) in advanced breast cancer, a multicentral cooperative dose finding study].
    Tominaga T; Abe O; Izuo M; Nomura Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):79-90. PubMed ID: 8422189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idoxifene: report of a phase I study in patients with metastatic breast cancer.
    Coombes RC; Haynes BP; Dowsett M; Quigley M; English J; Judson IR; Griggs LJ; Potter GA; McCague R; Jarman M
    Cancer Res; 1995 Mar; 55(5):1070-4. PubMed ID: 7866990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.